Tapewire

Nasdaq · USD

ACXP

Acurx Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
8195
SEC CIK
0001736243
Parsed reports
59

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 27, 2022 Filed Jul 29, 2022 17:02 UTC
Sailer CarlDirector
PurchaseWarrants for Common Stock · Derivative 19,737 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001104659-22-084317 · tm2222169-3_4seq1.xml · derivative · entry 4

Sailer Carl · CIK 0001854182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,737

Underlying: Common Stock · 19,737 shares

Expires 2028-01-27

Read SEC document
July 27, 2022 Filed Jul 29, 2022 17:02 UTC
Sailer CarlDirector
PurchaseWarrants for Common Stock · Derivative 19,737 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001104659-22-084317 · tm2222169-3_4seq1.xml · derivative · entry 3

Sailer Carl · CIK 0001854182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,737

Underlying: Common Stock · 19,737 shares

Expires 2024-01-27

Read SEC document
July 27, 2022 Filed Jul 29, 2022 17:02 UTC
Sailer CarlDirector
PurchaseCommon Stock 19,737 $3.80 $75,000.60
Disclosure

SEC source: 0001104659-22-084317 · tm2222169-3_4seq1.xml · nonDerivative · entry 1

Sailer Carl · CIK 0001854182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,815

Read SEC document
July 27, 2022 Filed Jul 29, 2022 17:01 UTC
LUCI DAVID PDirector · President and CEO · 10% owner
PurchaseWarrants for Common Stock · Derivative 19,737 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001104659-22-084315 · tm2222169-1_4seq1.xml · derivative · entry 5

LUCI DAVID P · CIK 0001271123 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,737

Underlying: Common Stock · 19,737 shares

Expires 2028-01-27

Read SEC document
July 27, 2022 Filed Jul 29, 2022 17:01 UTC
LUCI DAVID PDirector · President and CEO · 10% owner
PurchaseWarrants for Common Stock · Derivative 19,737 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001104659-22-084315 · tm2222169-1_4seq1.xml · derivative · entry 4

LUCI DAVID P · CIK 0001271123 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,737

Underlying: Common Stock · 19,737 shares

Expires 2024-01-27

Read SEC document
July 27, 2022 Filed Jul 29, 2022 17:01 UTC
LUCI DAVID PDirector · President and CEO · 10% owner
PurchaseCommon Stock 19,737 $3.80 $75,000.60
Disclosure

SEC source: 0001104659-22-084315 · tm2222169-1_4seq1.xml · nonDerivative · entry 1

LUCI DAVID P · CIK 0001271123 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,028,460

Read SEC document
December 02, 2021 Filed Jan 4, 2024 16:26 UTC
DELUCCIA ROBERT JDirector · 10% owner
GiftCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-001375 · tm242052-2_4seq1.xml · nonDerivative · entry 1

DELUCCIA ROBERT J · CIK 0001127423 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,011,198

F1 · kind: These transactions involved bona fide gifts by the Reporting Person of an aggregate of 110,000 shares of the Issuer's common stock to certain of the Reporting Person's family members who do not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by such family members, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. These transactions are late due to an inadvertent administrative error and not any error of the Reporting Person.

Read SEC document
November 23, 2021 Filed Nov 24, 2021 16:06 UTC
Sailer CarlDirector
PurchaseCommon Stock 5,161 $4.84 $24,979.24
Disclosure

SEC source: 0001104659-21-143551 · tm2133903-1_4seq1.xml · nonDerivative · entry 1

Sailer Carl · CIK 0001854182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,078

F1 · price: The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.73 to $4.86 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.

Read SEC document
November 19, 2021 Filed Nov 22, 2021 16:05 UTC
DELUCCIA ROBERT JDirector · 10% owner
PurchaseCommon Stock 5,034 $4.90 $24,671.63
Disclosure

SEC source: 0001104659-21-142473 · tm2133703-2_4seq1.xml · nonDerivative · entry 1

DELUCCIA ROBERT J · CIK 0001127423 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,031,461

F1 · price: The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.886 to $4.961 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.

Read SEC document
November 19, 2021 Filed Nov 22, 2021 16:05 UTC
LUCI DAVID PDirector · President and CEO · 10% owner
PurchaseCommon Stock 5,200 $4.80 $24,960.00
Disclosure

SEC source: 0001104659-21-142471 · tm2133703-1_4seq1.xml · nonDerivative · entry 1

LUCI DAVID P · CIK 0001271123 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,008,723

Read SEC document
July 01, 2021 Filed Jul 6, 2021 16:12 UTC GrantStock Option · Derivative 50,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0001104659-21-089408 · tm2121302d2_4seq1.xml · derivative · entry 1

Donohue James J. · CIK 0001869107 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-06-30

F1 · derivative.exercise_date: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 16:05 UTC
DELUCCIA ROBERT JDirector · 10% owner
GrantStock Option · Derivative 500,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0001104659-21-089392 · tm2121425-1_4seq1.xml · derivative · entry 2

DELUCCIA ROBERT J · CIK 0001127423 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2031-06-30

F2 · derivative.exercise_date: On July 1, 2021 (the "Employment Agreement Grant Date"), the Reporting Person was granted stock options to purchase 500,000 shares of the Issuer's common stock in connection with the Reporting Person's service as the Issuer's Executive Chairman pursuant to the Reporting Person's employment agreement. 25% of the stock options granted became vested and exercisable on the Employment Agreement Grant Date and 75% of the stock options shall become vested and exercisable as of each monthly anniversary from the Employment Agreement Grant Date, such that all stock options shall be fully vested and exercisable by July 1, 2024.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 16:13 UTC
Sailer CarlDirector
GrantStock Option · Derivative 50,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0001104659-21-089414 · tm2121302d4_4seq1.xml · derivative · entry 1

Sailer Carl · CIK 0001854182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-06-30

F1 · derivative.exercise_date: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 16:11 UTC
DEAN JACK HDirector
GrantStock Option · Derivative 50,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0001104659-21-089405 · tm2121302d1_4seq1.xml · derivative · entry 1

DEAN JACK H · CIK 0001434978 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-06-30

F1 · derivative.exercise_date: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 16:06 UTC
LUCI DAVID PDirector · President and CEO · 10% owner
GrantStock Option · Derivative 500,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0001104659-21-089396 · tm2121425-3_4seq1.xml · derivative · entry 2

LUCI DAVID P · CIK 0001271123 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2031-06-30

F2 · derivative.exercise_date: On July 1, 2021 (the "Employment Agreement Grant Date"), the Reporting Person was granted stock options to purchase 500,000 shares of the Issuer's common stock in connection with the Reporting Person's service as the Issuer's President and Chief Executive Officer pursuant to the Reporting Person's employment agreement. 25% of the stock options granted became vested and exercisable on the Employment Agreement Grant Date and 75% of the stock options shall become vested and exercisable as of each monthly anniversary from the Employment Agreement Grant Date, such that all stock options shall be fully vested and exercisable by July 1, 2024.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 20:13 UTC GrantStock Option · Derivative 50,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0001104659-21-089410 · tm2121302d3_4seq1.xml · derivative · entry 1

HARRISON THOMAS L · CIK 0001247340 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-06-30

F1 · derivative.exercise_date: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 16:15 UTC GrantStock Option · Derivative 50,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0001104659-21-089420 · tm2121302d5_4seq1.xml · derivative · entry 1

Scodari Joseph C · CIK 0001319892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-06-30

F1 · derivative.exercise_date: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 16:06 UTC
Shawah Robert G.Chief Financial Officer
GrantStock Option · Derivative 200,000 $0.00 Strike: $6.18 $0.00
Disclosure

SEC source: 0001104659-21-089393 · tm2121425-2_4seq1.xml · derivative · entry 2

Shawah Robert G. · CIK 0001601121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2031-06-30

F2 · derivative.exercise_date: On July 1, 2021 (the "Employment Agreement Grant Date"), the Reporting Person was granted stock options to purchase 200,000 shares of the Issuer's common stock in connection with the Reporting Person's service as the Issuer's Chief Financial Officer pursuant to the Reporting Person's employment agreement. 25% of the stock options granted became vested and exercisable on the Employment Agreement Grant Date and 75% of the stock options shall become vested and exercisable as of each monthly anniversary from the Employment Agreement Grant Date, such that all stock options shall be fully vested and exercisable by July 1, 2024.

Read SEC document
June 29, 2021 Filed Jul 6, 2021 16:05 UTC
DELUCCIA ROBERT JDirector · 10% owner
GrantStock Option · Derivative 350,000 $0.00 Strike: $6.26 $0.00
Disclosure

SEC source: 0001104659-21-089392 · tm2121425-1_4seq1.xml · derivative · entry 1

DELUCCIA ROBERT J · CIK 0001127423 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2031-06-28

F1 · derivative.exercise_date: On June 29, 2021 (the "June Grant Date"), the Reporting Person was granted stock options to purchase 350,000 shares of the Issuer's common stock. 40% of the stock options granted became vested and exercisable on the June Grant Date and 60% of the stock options shall become vested and exercisable as of each monthly anniversary from the June Grant Date, such that all stock options shall be fully vested and exercisable by June 29, 2024. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.

Read SEC document
June 29, 2021 Filed Jul 6, 2021 16:06 UTC
LUCI DAVID PDirector · President and CEO · 10% owner
GrantStock Option · Derivative 350,000 $0.00 Strike: $6.26 $0.00
Disclosure

SEC source: 0001104659-21-089396 · tm2121425-3_4seq1.xml · derivative · entry 1

LUCI DAVID P · CIK 0001271123 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2031-06-28

F1 · derivative.exercise_date: On June 29, 2021 (the "June Grant Date"), the Reporting Person was granted stock options to purchase 350,000 shares of the Issuer's common stock. 40% of the stock options granted became vested and exercisable on the June Grant Date and 60% of the stock options shall become vested and exercisable as of each monthly anniversary from the June Grant Date, such that all stock options shall be fully vested and exercisable by June 29, 2024. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.

Read SEC document
June 29, 2021 Filed Jul 6, 2021 16:06 UTC
Shawah Robert G.Chief Financial Officer
GrantStock Option · Derivative 70,000 $0.00 Strike: $6.26 $0.00
Disclosure

SEC source: 0001104659-21-089393 · tm2121425-2_4seq1.xml · derivative · entry 1

Shawah Robert G. · CIK 0001601121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2031-06-28

F1 · derivative.exercise_date: On June 29, 2021 (the "June Grant Date"), the Reporting Person was granted stock options to purchase 70,000 shares of the Issuer's common stock. 40% of the stock options granted became vested and exercisable on the June Grant Date and 60% of the stock options shall become vested and exercisable as of each monthly anniversary from the June Grant Date, such that all stock options shall be fully vested and exercisable by June 29, 2024. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.

Read SEC document
June 29, 2021 Filed Sep 10, 2021 16:16 UTC
Sailer CarlDirector
PurchaseCommon Stock 12,500 $6.00 $75,000.00
Disclosure

SEC source: 0001104659-21-114674 · tm2127171d1_4.xml · nonDerivative · entry 1

Sailer Carl · CIK 0001854182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,917

F1 · shares: Represents shares of common stock of Acurx Pharmaceuticals, Inc. (the "Issuer") purchased by the reporting person in connection with the Issuer's initial public offering, which closed on June 29, 2021. Due to an unintentional oversight, the transaction reported on this Form 4 was not previously filed on a Form 4 in a timely manner and was omitted from one Form 4 that was subsequently filed. The 12,500 shares of common stock of the Issuer were purchased at the initial public offering price of $6.00 per share.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.